Low dose valganciclovir as cytomegalovirus prophylaxis in post-renal transplant recipients induced with alemtuzumab: A single-center study Article (Web of Science)

cited authors

  • Korneffel, Katie; Mitro, Graham; Buschor, Kellie; Rees, Michael; Ortiz, Jorge

authors

publication date

  • October 1, 2019

webpage

published in

category

keywords

  • Alemtuzumab
  • CMV
  • Renal transplantation
  • Valganciclovir

volume

  • 56